Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057593) titled 'Novel Fecal Biomarker for Irritable Bowel Syndrome' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Tohoku University
Condition:
Condition - Patients with Irritable Bowel Syndrome and Healthy Subjects
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Comparing the composition of membrane vesicles between patients with irritable bowel syndrome and healthy subjects
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - IBS patients: meet Rome IV criteria for IBS and do not meet the e...